Free Trial
OTCMKTS:GBLX

GB Sciences (GBLX) Stock Price, News & Analysis

GB Sciences logo
$0.0002 0.00 (-50.00%)
As of 04/17/2025 03:04 PM Eastern

About GB Sciences Stock (OTCMKTS:GBLX)

Key Stats

Today's Range
$0.0002
$0.0002
50-Day Range
N/A
52-Week Range
$0.0001
$0.0135
Volume
4,320 shs
Average Volume
96,509 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

GB Sciences, Inc., a phytomedical research and biopharmaceutical drug development company, engages in the research and development of plant-based medicines. The company offers cannabinoid-inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of medical conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and cardiovascular therapeutic programs. The company was formerly known as Growblox Sciences, Inc. and changed its name to GB Sciences, Inc. in October 2016. GB Sciences, Inc. was incorporated in 2001 and is based in Las Vegas, Nevada.

Receive GBLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GB Sciences and its competitors with MarketBeat's FREE daily newsletter.

GBLX Stock News Headlines

GB Sciences Reports Delay in Quarterly Filing
GB Sciences, Inc. (GBLX) stock forecast and price target
Elon Reveals Why There Soon Won’t Be Any Money For Social Security
Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a terrifying supercar crash with billionaire Peter Thiel, then from a deadly strain of malaria—Elon Musk emerged with a stark warning for Americans about looming financial dangers. Discover the little-known Trump IRS loophole that thousands are now using to safeguard their retirement from inflation and market turmoil—before it's too late.
GB Sciences Inc (GBLX)
See More Headlines

GBLX Stock Analysis - Frequently Asked Questions

GB Sciences' stock was trading at $0.0040 at the beginning of 2025. Since then, GBLX shares have decreased by 95.0% and is now trading at $0.0002.
View the best growth stocks for 2025 here
.

GB Sciences, Inc. (OTCMKTS:GBLX) posted its earnings results on Monday, November, 14th. The company reported ($0.04) EPS for the quarter.

Shares of GBLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that GB Sciences investors own include Canopy Growth (CGC), 22nd Century Group (XXII), NVIDIA (NVDA), Unrivaled Brands (TRTC), Trees (CANN), Aurora Cannabis (ACB) and Meta Platforms (META).

Company Calendar

Last Earnings
11/14/2016
Today
4/21/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biotechnology
Sub-Industry
Cannabis
Current Symbol
OTCMKTS:GBLX
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (OTCMKTS:GBLX) was last updated on 4/21/2025 by MarketBeat.com Staff
From Our Partners